glp-1 mash therapies may be doing more than promoting weight loss. New evidence suggests semaglutide may provide direct liver protection in through intrahepatic GLP-1 receptors, adding to the growing evidence of organ mash glp 1 Incretin-based therapies

Osteoporos Int 30(8):17091710 Thomas MK, Nikooienejad A, Bray R et al (2021) Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes

There is a lot of excitement and demand for these medications, but side effects are critical points for discussion, Prateek Sharma, MD, a Professor of Medicine in the Department of Medical Oncology at the University of Kansas School of Medicine, and lead investigator of the study, told Healthline

Effects of doxocuribicin-containing chemotherapy and a combination with L-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma

& Spaeth, A

They promise grand results, but the reality looks a lot different

Use in woundhealing and tissueinjury models : Investigated in rat subcutaneous wound chambers and skininjury paradigms, to assess effects on connectivetissue accumulation, angiogenesis, inflammatory markers, and antioxidant enzyme activity